Almac Discovery to share latest developments in first-in-class DUB inhibitors at the at 8th Proteasome and Autophagy Congress
Almac Discovery, a biopharmaceutical company with a key research focus in the area of deubiquitylating enzyme therapeutic discovery, has had its work recognised ...




















